The Seventh International Childhood Acute Lymphoblastic Leukemia Workshop Report: Palermo, Italy, January 29--30, 2005

Overview

Journal Leukemia

Specialties Hematology
Oncology

Date 2005 May 20

PMID 15902295

Citations 9

Authors

M Arico

A Baruchel

Y Bertrand

A Biondi

V Conter

T Eden

H Gadner

P Gaynon

K Horibe

S P Hunger

G Janka-Schaub

G Masera

J Nachman

R Pieters

M Schrappe

K Schmiegelow

M G Valsecchi

C-H Pui

Affiliations

Soon will be listed here.

Abstract

Between 1995 and 2004, six International Childhood Acute Lymphoblastic Leukemia (ALL) Workshop have been held, and the completion of several collaborative projects has established the clinical relevance and treatment options for several specific genetic subtypes of ALL. This meeting report summarizes the data presented in the seventh meeting and the discussion.

Citing Articles

Increments in DNA-thioguanine level during thiopurine-enhanced maintenance therapy of acute lymphoblastic leukemia.

Larsen R, Rank C, Grell K, Moller L, Overgaard U, Kampmann P Haematologica. 2021; 106(11):2824-2833.

PMID: 34047177 PMC: 8561300. DOI: 10.3324/haematol.2020.278166.

Pharmacokinetics of tablet and liquid formulations of oral 6-mercaptopurine in children with acute lymphoblastic leukemia.

Larsen R, Hjalgrim L, Grell K, Kristensen K, Pedersen L, Brunner E Cancer Chemother Pharmacol. 2020; 86(1):25-32.

PMID: 32519032 DOI: 10.1007/s00280-020-04097-x.

Mercaptopurine Ingestion Habits, Red Cell Thioguanine Nucleotide Levels, and Relapse Risk in Children With Acute Lymphoblastic Leukemia: A Report From the Children's Oncology Group Study AALL03N1.

Landier W, Hageman L, Chen Y, Kornegay N, Evans W, Bostrom B J Clin Oncol. 2017; 35(15):1730-1736.

PMID: 28339328 PMC: 5455766. DOI: 10.1200/JCO.2016.71.7579.

NUDT15 polymorphisms alter thiopurine metabolism and hematopoietic toxicity.

Moriyama T, Nishii R, Perez-Andreu V, Yang W, Klussmann F, Zhao X Nat Genet. 2016; 48(4):367-73.

PMID: 26878724 PMC: 5029084. DOI: 10.1038/ng.3508.

Model-Based Individualized Treatment of Chemotherapeutics: Bayesian Population Modeling and Dose Optimization.

Jayachandran D, Lainez-Aguirre J, Rundell A, Vik T, Hannemann R, Reklaitis G PLoS One. 2015; 10(7):e0133244.

PMID: 26226448 PMC: 4520687. DOI: 10.1371/journal.pone.0133244.